The company said the discontinuation was due to several reasons,” Reuters news service reported, “including limited interest in gene therapies for the bleeding disorder.” (Pfizer had earlier dumped a ...

Leaders at the FDA, HHS and elsewhere are putting guardrails around COVID-19 boosters, which could mean delayed shots or ...

Both the FDA and EMA have suspended Ixchiq’s use in older adults after post-marketing serious adverse events that include two ...

Houston-based Empower Pharmacy has repeatedly been admonished by the FDA for failing to follow federal rules that ensure drug ...

Participants who took tirzepatide — which is sold as Zepbound by Eli Lilly — lost an average of 50 pounds over 72 weeks.

The executive order aims to cut US prescription drug costs by linking them to the lowest prices paid internationally.

GREEN BAY, Wis. (WBAY) - The Food and Drug Administration announced a new screening tool for cervical cancer, and this could be a game changer. The FDA approved an at-home test that will let women ...

Empower Pharmacy, a Houston-based compounding pharmacy, has attracted media attention over the last decade for its rapid expansion in the region, with the company opening two large facilities that ...

About 600 college leaders recently signed a letter opposing the Trump administration's interference in higher education. The ...

Net Loss: BioXcel Therapeutics had a net loss of $7.3 million for the first quarter of 2025, compared to a net loss of $26.8 ...

Trump's proposal would likely only impact certain drugs covered by Medicare and given in an office — think infusions that treat cancer, and other injectables.